文献速递主动脉疾病

不适合开放手术患者行EVAR的当代结局

Contemporary outcomes of endovascular abdominal aortic aneurysm repair in patients deemed unfit for open surgical repair.
PubMed 文献 · J Vasc Surg · 2020-10-06

基于Vascular Quality Initiative数据库2013至2019年16183例择期EVAR(腹主动脉瘤>5 cm),其中1782例被判定为不适合开放手术。该组围术期死亡率和1年、5年死亡率均显著高于适合组,不适合开放手术是围术期和长期死亡的独立预测因素。

要点

  • 不适合开放手术者EVAR后围术期死亡率1.7%,显著高于适合组的0.6%。
  • 不适合开放手术者1年和5年死亡率分别为13%和29%,远高于适合组的5%和14%。
  • 因腹部条件恶劣判定为不适合者,EVAR后1年和5年死亡率低于因心肺功能不全或衰弱者。

核心结论

  • 尽管围术期死亡率低,被术者判定为不适合开放手术的患者行择期EVAR后长期死亡率相当高,可能归因于医学衰弱导致的竞争性死亡风险。
  • 因腹部条件恶劣判定为不适合开放手术并未在EVAR后带来额外风险。
  • 考虑该亚组患者的治疗选择时,审慎评估预期寿命至关重要。

研究设计与样本

  • 回顾性队列研究,查询Vascular Quality Initiative数据库2013至2019年因腹主动脉瘤>5 cm行择期EVAR的患者。
  • 共纳入16183例EVAR,按是否适合开放手术分为适合组和不适合组,其中1782例被判定为不适合开放手术。

主要发现

  • 不适合组患者更可能年龄较大、女性,且高血压、冠心病、充血性心力衰竭、慢性阻塞性肺疾病和动脉瘤直径更大的比例更高。
  • 不适合组术后心肺并发症发生率6.5%,高于适合组的3%(P < .001)。
  • 不适合组围术期死亡率1.7%,高于适合组的0.6%(P < .001)。
  • 不适合组1年和5年死亡率分别为13%和29%,适合组分别为5%和14%(P < .001)。
  • 不适合组中因腹部条件恶劣者1年和5年死亡率分别为6%和20%,因心肺功能不全和衰弱者分别为14%和30%(P = .451)。

关键数值与推荐

  • 不适合组1年和5年无再干预生存率分别为85%和68%,适合组分别为93%和82%(P < .001)。
  • 不适合开放手术是围术期死亡的独立预测因素(OR 1.59;95%CI 1.03-2.46;P = .038)。
  • 不适合开放手术是长期死亡的独立预测因素(HR 1.92;95%CI 1.69-2.17;P < .001)。
  • 高龄是围术期死亡的最强决定因素(OR 2.91;95%CI 1.28-6.66;P = .011)。
  • 终末期肾病是长期死亡的最强预测因素(HR 2.51;95%CI 1.78-3.55;P < .001);他汀使用(HR 0.77;95%CI 0.69-0.87;P < .001)和ACEI使用(HR 0.83;95%CI 0.75-0.93;P < .001)对长期死亡有保护作用。

临床怎么用

  • 对判定为不适合开放手术的患者行择期EVAR前,应审慎评估预期寿命并权衡长期死亡风险。
  • 因腹部条件恶劣判定为不适合开放手术并非EVAR的额外风险因素,可据此个体化决策。
  • 他汀和ACEI使用与长期死亡风险降低相关,可作为围术期管理的参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovascular abdominal aortic aneurysm repair (EVAR) has been preferred to open surgical repair (OSR) for the treatment of abdominal aortic aneurysms (AAAs) in high-risk patients. We compared the perioperative and long-term outcomes of EVAR for patients designated as unfit for OSR using a large national dataset. METHODS: The Vascular Quality Initiative database was queried for patients who had undergone elective EVAR for AAAs >5 cm from 2013 to 2019. The patients were stratified into two cohorts according to their suitability for OSR (fit vs unfit). The primary outcomes included perioperative (in-hospital) major adverse events, perioperative mortality, and mortality at 1 and 5 years. Patient demographics and postoperative outcomes were analyzed to identify the predictors of perioperative and long-term mortality. RESULTS: Of 16,183 EVARs, 1782 patients had been deemed unfit for OSR. The unfit cohort was more likely to be older and female, with a greater proportion of hypertension, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, and larger aneurysm diameters. Postoperatively, the unfit cohort was more likely to have experienced cardiopulmonary complications (6.5% vs 3%; P < .001), with greater perioperative mortality (1.7% vs 0.6%; P < .001) and 1- and 5-year mortality (13% and 29% for the unfit vs 5% and 14% for the fit cohorts, respectively; P < .001). A subgroup analysis of the unfit cohort revealed that those deemed unfit because of a hostile abdomen had significantly lower 1- and 5-year mortality (6% and 20%, respectively) compared with those considered unfit because of cardiopulmonary compromise and frailty (14% and 30%, respectively; P = .451). Reintervention-free survival at 1 and 5 years was significantly greater in the fit cohort (93% and 82%, respectively) compared with that for the unfit cohort (85% and 68%, respectively; P < .001). The designation as unfit for OSR was an independent predictor of both perioperative (odds ratio, 1.59; 95% confidence interval [CI], 1.03-2.46; P = .038) and long-term mortality (hazard ratio [HR], 1.92; 95% CI, 1.69-2.17; P < .001). Advanced age (odds ratio, 2.91; 95% CI, 1.28-6.66; P = .011) was the strongest determinant of perioperative mortality, and end-stage renal disease (HR, 2.51; 95% CI, 1.78-3.55; P < .001) was the strongest predictor of long-term mortality. Statin use (HR, 0.77; 95% CI, 0.69-0.87; P < .001) and angiotensin-converting enzyme inhibitor use (HR, 0.83; 95% CI, 0.75-0.93; P < .001) were protective of long-term mortality. CONCLUSIONS: Despite low perioperative mortality, the long-term mortality of those designated by operating surgeons as unfit for OSR was rather high for patients undergoing elective EVAR, likely owing to the competing risk of death from medical frailty. An unfit designation because of a hostile abdomen did not confer any additional risks after EVAR. Judicious estimation of the patient's life expectancy is essential when considering the treatment options for this subset of patients deemed unfit for OSR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Chang H, Rockman CB, Jacobowitz GR, et al. Contemporary outcomes of endovascular abdominal aortic aneurysm repair in patients deemed unfit for open surgical repair. J Vasc Surg. 2020. PMID: 33035595. doi:10.1016/j.jvs.2020.08.147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。